Pharmaceutical composition for treating chronic nephritis
A technology of chronic nephritis and composition, which is applied in the field of traditional Chinese medicine, can solve the problems of increasing patients' pain, side effects of patients, and ineffective curative effect, and achieve the effects of low cost, improvement of renal function, and significant and reliable curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0026] A pharmaceutical composition for treating chronic nephritis, which is prepared from the following raw materials in weight ratio:
[0027] 40 parts of schisandra, 40 parts of Chuanxiong, 35 parts of astragalus, 35 parts of epimedium, 30 parts of Ligustrum lucidum,
[0028] Poria cocos 30 parts, dandelion 30 parts, houttuynia cordata 30 parts, magnolia bark 30 parts, white lentils 25 parts,
[0029] 25 parts of Lingxiaohua, 25 parts of Guizhi, 25 parts of Citrus aurantium, 20 parts of Hedyotis diffusa, 20 parts of Imperata rhizome,
[0030] 20 parts of Morus alba, 20 parts of Salvia miltiorrhiza, 15 parts of jujube seed, 15 parts of dodder seed, 15 parts of atractylodes rhizome,
[0031] 10 parts Anemarrhena, 10 parts Alisma, 10 parts Aconite, 8 parts licorice, 5 parts peach kernel.
[0032] The preparation method of described pharmaceutical composition is:
[0033] 1) take each raw material and set aside;
[0034] 2) Take schisandra, Chuanxiong, Ligustrum lucidum, Po...
Embodiment 2
[0038] clinical information
[0039]A total of 135 patients were admitted in the clinic, 78 were males and 57 were females, the oldest was 65 years old and the youngest was 30 years old. The course of disease was randomly divided into an experimental group of 70 cases and a control group of 65 cases. The differences were not statistically significant (P<0.05), and they were comparable.
[0040] Diagnostic criteria
[0041] Refer to the diagnostic criteria revised by the 2nd National Academic Conference of Nanjing Chinese Society of Nephrology in 1985.
[0042] (1) The onset is slow, the disease is protracted, sometimes mild and sometimes severe, renal function gradually declines, anemia, electrolyte disturbance, blood urea nitrogen, blood creatinine increase and so on may appear in the later stage.
[0043] (2) Different degrees of proteinuria, hematuria, edema and hypertension.
[0044] (3) Acute attacks can be induced by respiratory tract infection and other reasons dur...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com